Asp Isotopes [ASPI] vs Rex American [REX] Detailed Stock Comparison
Asp Isotopes
NASDAQ
Loading...
Rex American
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Asp Isotopes wins in 7 metrics, Rex American wins in 11 metrics, with 0 ties. Rex American appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Asp Isotopes | Rex American | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -14.17 | 15.79 | Asp Isotopes |
| Price-to-Book Ratio | 15.14 | 1.57 | Rex American |
| Debt-to-Equity Ratio | 84.08 | 4.23 | Rex American |
| PEG Ratio | -59.53 | 22.46 | Asp Isotopes |
| EV/EBITDA | -23.83 | 7.98 | Asp Isotopes |
| Profit Margin (TTM) | 38.60% | 8.86% | Asp Isotopes |
| Operating Margin (TTM) | -721.89% | 5.30% | Rex American |
| EBITDA Margin (TTM) | N/A | 5.30% | N/A |
| Return on Equity | -115.46% | 11.48% | Rex American |
| Return on Assets (TTM) | -26.14% | 5.90% | Rex American |
| Free Cash Flow (TTM) | $-28.07M | $-7.13M | Rex American |
| 1-Year Return | 313.43% | 9.00% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 185.28 | 1.31 | Rex American |
| Enterprise Value | $666.51M | $633.30M | Asp Isotopes |
| EV/Revenue Ratio | 151.29 | 0.99 | Rex American |
| Gross Profit Margin (TTM) | 29.67% | 9.06% | Asp Isotopes |
| Revenue per Share (TTM) | $0 | $37 | Rex American |
| Earnings per Share (Diluted) | $-0.59 | $3.23 | Rex American |
| Beta (Stock Volatility) | 3.38 | 0.56 | Rex American |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Asp Isotopes vs Rex American Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Asp Isotopes | -1.54% | -14.71% | 27.57% | 65.37% | 55.30% | 80.77% |
| Rex American | -2.47% | -5.78% | 2.60% | 27.16% | 23.40% | 19.39% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Asp Isotopes | 313.43% | 218.93% | 218.93% | 218.93% | 218.93% | 218.93% |
| Rex American | 9.00% | 63.38% | 124.92% | 211.48% | 895.90% | 944.88% |
Performance & Financial Health Analysis: Asp Isotopes vs Rex American
| Metric | ASPI | REX |
|---|---|---|
| Market Information | ||
| Market Cap | $816.25M | $839.75M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,793,356 | 82,870 |
| 90 Day Avg. Volume | 4,457,119 | 117,083 |
| Last Close | $8.93 | $50.99 |
| 52 Week Range | $1.86 - $10.82 | $33.45 - $55.36 |
| % from 52W High | -17.47% | -7.89% |
| All-Time High | $10.82 (Jul 25, 2025) | $60.79 (Apr 01, 2024) |
| % from All-Time High | -17.47% | -16.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | -0.02% |
| Quarterly Earnings Growth | 0.31% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.39% | 0.09% |
| Operating Margin (TTM) | -7.22% | 0.05% |
| Return on Equity (TTM) | -1.15% | 0.11% |
| Debt to Equity (MRQ) | 84.08 | 4.23 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.59 | $32.56 |
| Cash per Share (MRQ) | $0.75 | $19.18 |
| Operating Cash Flow (TTM) | $-16,894,872 | $62.98M |
| Levered Free Cash Flow (TTM) | $-20,013,620 | $-25,565,124 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Asp Isotopes vs Rex American
| Metric | ASPI | REX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -14.17 | 15.79 |
| Forward P/E | -59.53 | 22.46 |
| PEG Ratio | -59.53 | 22.46 |
| Price to Sales (TTM) | 185.28 | 1.31 |
| Price to Book (MRQ) | 15.14 | 1.57 |
| Market Capitalization | ||
| Market Capitalization | $816.25M | $839.75M |
| Enterprise Value | $666.51M | $633.30M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 151.29 | 0.99 |
| Enterprise to EBITDA | -23.83 | 7.98 |
| Risk & Other Metrics | ||
| Beta | 3.38 | 0.56 |
| Book Value per Share (MRQ) | $0.59 | $32.56 |
Financial Statements Comparison: Asp Isotopes vs Rex American
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASPI | REX |
|---|---|---|
| Revenue/Sales | $1.10M | $158.34M |
| Cost of Goods Sold | $774,765 | $144.00M |
| Gross Profit | $326,840 | $14.34M |
| Research & Development | $1.53M | N/A |
| Operating Income (EBIT) | $-7.95M | $8.40M |
| EBITDA | $-8.23M | $13.42M |
| Pre-Tax Income | $-8.53M | $13.63M |
| Income Tax | $-70,720 | $2.95M |
| Net Income (Profit) | $-8.46M | $10.67M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASPI | REX |
|---|---|---|
| Cash & Equivalents | $55.97M | $159.91M |
| Total Current Assets | $59.03M | $398.77M |
| Total Current Liabilities | $8.18M | $42.58M |
| Long-Term Debt | $36.96M | $19.04M |
| Total Shareholders Equity | $45.73M | $619.64M |
| Retained Earnings | $-64.62M | $768.61M |
| Property, Plant & Equipment | $1.02M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASPI | REX |
|---|---|---|
| Operating Cash Flow | $-7.16M | $-2.75M |
| Capital Expenditures | $-2.36M | N/A |
| Free Cash Flow | $-5.53M | $-10.38M |
| Debt Repayment | $-262,304 | N/A |
| Common Stock Repurchase | N/A | $-32.67M |
Short Interest & Institutional Ownership Analysis
| Metric | ASPI | REX |
|---|---|---|
| Shares Short | 16.34M | 462,118 |
| Short Ratio | 4.67 | 3.35 |
| Short % of Float | 0.24% | 0.04% |
| Average Daily Volume (10 Day) | 4,793,356 | 82,870 |
| Average Daily Volume (90 Day) | 4,457,119 | 117,083 |
| Shares Outstanding | 72.07M | 17.19M |
| Float Shares | 54.53M | 14.45M |
| % Held by Insiders | 0.23% | 0.14% |
| % Held by Institutions | 0.37% | 0.88% |
Dividend Analysis & Yield Comparison: Asp Isotopes vs Rex American
| Metric | ASPI | REX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |